Next Article in Journal
Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment
Next Article in Special Issue
Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer
Previous Article in Journal
Construction of a Nomogram to Predict Overall Survival in Patients with Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study
Previous Article in Special Issue
Cellular Therapy for Lung Cancer: Focusing on Chimeric Antigen Receptor T (CAR T) Cells and Tumor-Infiltrating Lymphocyte (TIL) Therapy
 
 
Article

Article Versions Notes

Cancers 2023, 15(22), 5312; https://doi.org/10.3390/cancers15225312
Action Date Notes Link
article xml file uploaded 7 November 2023 10:32 CET Original file -
article xml uploaded. 7 November 2023 10:32 CET Update https://www.mdpi.com/2072-6694/15/22/5312/xml
article pdf uploaded. 7 November 2023 10:32 CET Version of Record https://www.mdpi.com/2072-6694/15/22/5312/pdf
article supplementary file uploaded. 7 November 2023 10:32 CET - https://www.mdpi.com/2072-6694/15/22/5312#supplementary
article html file updated 7 November 2023 10:33 CET Original file https://www.mdpi.com/2072-6694/15/22/5312/html
Back to TopTop